Clincosm LogoSign in Get a demo

toxicity, drug

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Indian Children With Acute Lymphoblastic Leukemia

Not yet recruiting
  • ALL, Childhood
  • +7 more
    • New Delhi, India
    • +1 more
    Aug 22, 2022

    Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

    Recruiting
    • Toxicity, Drug
    • +2 more
    • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
    • Leiden, Netherlands
      Leiden University Medical Center
    Aug 16, 2022

    Toxicity, Drug Trial in Hefei (neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery)

    Recruiting
    • Toxicity, Drug
    • neoadjuvant chemoradiotherapy combined with Camrelizumab and Nimotuzumab followed by surgery
    • Hefei, Anhui, China
      Anhui Provicial Hospital
    May 1, 2022

    Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

    Completed
    • Effect of Drug
    • +2 more
    • Apatinib Mesylate
    • ifosfamide and etoposide
    • Beijing, Beijing, China
      Peking University People's Hospital
    Mar 12, 2022

    Toxicity, Drug, Maculopathy Trial in Paris (spectral domain optical coherence tomography C-scan and multifocal

    Completed
    • Toxicity, Drug
    • Maculopathy
    • spectral domain optical coherence tomography C-scan and multifocal electroretinogram
    • Paris, France
      Fondation Ophtalmique Adolphe de Rothschild
    Dec 17, 2021

    Effect of Drug, Toxicity, Drug Trial in Beijing (apatinib)

    Recruiting
    • Effect of Drug
    • Toxicity, Drug
    • Beijing, Beijing, China
    • +1 more
    Jul 12, 2021

    Adductor Canal Block

    Recruiting
    • Toxicity, Drug
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Jun 2, 2021

    Efficacy, Toxicity, Drug Trial in Beijing (Apatinib Mesylate)

    Completed
    • Efficacy
    • Toxicity, Drug
    • Apatinib Mesylate
    • Beijing, Beijing, China
    • +1 more
    Jan 2, 2021

    Toxicity, Drug Trial in Tanta (Paraffin oil gastric lavage, Gastric lavage with saline and sodium bicarbonate 8.4%)

    Recruiting
    • Toxicity, Drug
    • Paraffin oil gastric lavage
    • Gastric lavage with saline and sodium bicarbonate 8.4%
    • Tanta, Egypt
      Sherief Abd-Elsalam
    Aug 1, 2020

    Osteosarcoma, Survival, Chemo Effect Trial in Beijing (MAPI chemo, Apatinib Mesylate, Camrelizumab)

    Unknown status
    • Osteosarcoma
    • +3 more
    • MAPI chemotherapy
    • +2 more
    • Beijing, China
      Peking University People's Hospital
    May 15, 2020